Group One Trading
IBIO icon

Group One Trading’s iBio IBIO Stock Holding History

Group One Trading’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-103,600
Closed -$142K – 7441
2023
Q4 		$142K Buy
103,600
+98,255
+1,838% +$429K ﹤0.01% 4171
2023
Q3 		$32.4K Sell
5,345
-2,265
-30% -$19.6K ﹤0.01% 5474
2023
Q2 		$92.8K Sell
7,610
-10
-0.1% -$189 ﹤0.01% 4700
2023
Q1 		$317K Buy
7,620
+5,140
+207% +$132K ﹤0.01% 3215
2022
Q4 		$22K Buy
2,480
+2,382
+2,431% +$80.6K ﹤0.01% 5539
2022
Q3 		$8K Buy
98
+69
+238% +$9.5K ﹤0.01% 6628
2022
Q2 		$4K Sell
29
-9
-24% -$1.35K ﹤0.01% 7197
2022
Q1 		$8K Sell
38
-262
-87% -$54.8K ﹤0.01% 7245
2021
Q4 		$82K Sell
300
-212
-41% -$80.8K ﹤0.01% 5904
2021
Q3 		$271K Buy
512
+172
+51% +$107K ﹤0.01% 4851
2021
Q2 		$256K Buy
340
+86
+34% +$62.7K ﹤0.01% 4958
2021
Q1 		$195K Buy
254
+5
+2% +$4.36K ﹤0.01% 5060
2020
Q4 		$131K Sell
249
-167
-40% -$136K ﹤0.01% 4368
2020
Q3 		$422K Buy
+416
New +$603K ﹤0.01% 2991

Other funds holding IBIO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Group One Trading's IBIO Position: Q2 2025 in Review

Group One Trading sold out of iBio (IBIO) in Q2 2025, closing a stake of 156 shares — an estimated $627 sold.

Group One Trading first reported a position in IBIO in Q3 2020 and held it in 17 quarters. The position peaked at $125K in Q3 2021. 30 funds tracked by Wall St. Rank hold IBIO as of Q2 2025.

  • Group One Trading reported no remaining iBio position as of Q2 2025 after selling out during the quarter.
  • Group One Trading sold 156 iBio shares in Q2 2025, an estimated $627.
  • Group One Trading first reported a position in iBio in Q3 2020 and held it in 17 quarters.
  • Group One Trading's iBio position peaked at $125K in Q3 2021.
  • 30 funds tracked by Wall St. Rank held iBio as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.